Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes.
It has recently been shown that measurable amounts of complement proteins, C6 and in particular C7, are released from human polymorphonuclear leukocytes (PMNs). The aim of the present study was to investigate the impact of opsonized Candida albicans on this release. Stimulation with opsonized C. albicans led to a rapid and sustained increase of C6 and C7 in the cell culture supernatant beginning within 5 min of placing in co-culture, whereas co-culture with unopsonized C. albicans or C. albicans mock-opsonized with inactivated human serum did not affect the release. In contrast, even after stimulation employing opsonized C. albicans, no release of the complement component C8 and only trace amounts of C9 were detected. The presence of the membrane attack complex (MAC) on C. albicans after opsonization was demonstrated by indirect immunofluorescence. Opsonization of C. albicans with human serum deficient in or depleted of a terminal complement component resulted in only minor stimulation of C6 and C7 release, although C3 deposition on the surface of C. albicans was not affected as determined by direct immunofluorescence. Detailed analyses with inactivated or deficient sera showed that detection of C6 and C7 was not due to insufficient washing of the opsonized yeast prior to co-culture and suggest that only a small proportion of these proteins was derived from the membrane bound and then cleaved off MAC. Thus, these findings imply that MAC on the fungal surface may represent an additional trigger for the release of C6 and C7 from PMNs, suggesting a new role for the terminal complement complex (TCC) on target membranes as modulator of PMN functions locally at the site of inflammation.
Lukasser-Vogl
E
E
Institute of Hygiene, University of Innsbruck, Fritz-Pregl-Str. 3, A-6020, Innsbruck, Austria.
Gruber
A
A
Lass-Flörl
C
C
Eder
A
A
Høgåsen
A K
AK
Morgan
B P
BP
Dierich
M P
MP
Würzner
R
R
D002175:Candida / Q000276:immunology; D002176:Candida albicans / Q000276:immunology; D002470:Cell Survival; D002478:Cells, Cultured; D003183:Complement C6 / Q000378:metabolism; D003184:Complement C7 / Q000378:metabolism; D015938:Complement Membrane Attack Complex / Q000378:metabolism*; D003165:Complement System Proteins / Q000378:metabolism*; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism; D009895:Opsonin Proteins / Q000276:immunology; D012441:Saccharomyces cerevisiae / Q000276:immunology; D015003:Yeasts / Q000276:immunology* / Q000378:metabolism
D003183:Complement C6; D003184:Complement C7; D015938:Complement Membrane Attack Complex; D009895:Opsonin Proteins; D003165:Complement System Proteins